Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia.
NCT ID: NCT07058389
Last Updated: 2025-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
45 participants
INTERVENTIONAL
2025-10-07
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life
NCT03757988
Physical Activity, Psychopathology, and Quality of Life in People With Psychotic or Affective Disorders
NCT05869409
The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.
NCT01897064
Aerobic Exercise for the Improvement of Cognition and Enhancement of Recovery in Post-acute Schizophrenia
NCT03466112
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
NCT05890183
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
INT group
8-week indoor physical activity program (in a gymnasium)
8-week indoor physical activity program
INT group will perform aerobic and resistance exercises with a coach in adapted physical activities, inside a conventional gym.
Sessions will be typically composed as follows:
* Warm-up (20 min)
* Aerobic exercise (30 min) at RPE 4 to 7 on the Borg scale
* Muscular strengthening (25 min) at RPE 4 to 7 on the Borg scale
* Cool-down, stretching and balance (15 min) INT group will train for 8 weeks, twice a week for 1h30, following WHO recommendation.
EXT group
8-week outdoor physical activity program
8-week outdoor physical activity program
EXT group will perform aerobic and resistance exercises with a coach in adapted physical activities on a green environment in a parc.
Sessions will be typically composed as follows:
* Warm-up (20 min)
* Aerobic exercise (30 min) at RPE 4 to 7 on the Borg scale
* Muscular strengthening (25 min) at RPE 4 to 7 on the Borg scale
* Cool-down, stretching and balance (15 min) EXR group will train for 8 weeks, twice a week for 1h30, following WHO recommendation.
TEM group
Without physical activiy program (no change in routine)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
8-week outdoor physical activity program
EXT group will perform aerobic and resistance exercises with a coach in adapted physical activities on a green environment in a parc.
Sessions will be typically composed as follows:
* Warm-up (20 min)
* Aerobic exercise (30 min) at RPE 4 to 7 on the Borg scale
* Muscular strengthening (25 min) at RPE 4 to 7 on the Borg scale
* Cool-down, stretching and balance (15 min) EXR group will train for 8 weeks, twice a week for 1h30, following WHO recommendation.
8-week indoor physical activity program
INT group will perform aerobic and resistance exercises with a coach in adapted physical activities, inside a conventional gym.
Sessions will be typically composed as follows:
* Warm-up (20 min)
* Aerobic exercise (30 min) at RPE 4 to 7 on the Borg scale
* Muscular strengthening (25 min) at RPE 4 to 7 on the Borg scale
* Cool-down, stretching and balance (15 min) INT group will train for 8 weeks, twice a week for 1h30, following WHO recommendation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having persistent negative symptoms (SNS), negative symptoms self-assessment scale \> 7
* Regularly monitored in the psychiatry department.
* Have no medical contraindications to physical activity
* Subject affiliated with or entitled to a social security system.
* Subject having received informed information about the study and having co-signed, with the investigator, consent to participate in the study.
* Male or female.
Exclusion Criteria
* Any subject with chronic joint pathologies (example: repeated sprains, patellar or ligament problems) or cardiac pathologies.
* Any subject presenting chronic or central neurological pathologies.
* Any subject deprived of liberty or subject to legal protection
* Excessive consumption of alcohol (\> 14 glasses per week) or caffeinated drinks (\> 400 mg of coffee per day).
* Pregnant women.
* Subject unable to understand the purpose and conditions of the study, unable to give consent.
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jean Monnet University
OTHER
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medhi HOUSNI, Md
Role: PRINCIPAL_INVESTIGATOR
CHU de Saint-Etienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Saint-Etienne
Saint-Etienne, France, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00700-49
Identifier Type: OTHER
Identifier Source: secondary_id
25CH062
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.